US Stocks
US Options
ETFs
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewA
ABBV
Abbvie Inc
233.86
-0.40-0.17%After Hours: 233.20 -0.66 -0.28%19:58 03/03 EST
OPEN/PREV CLOSE233.36/234.26
TODAY RANGE230.24-235.71
VOL6.60M
MARKET CAP413.50B
52 WEEK RANGE159.05-241.12
AVG VOL (3M)6.63M
% TURNOVER0.37%
TURNOVER--
P/E (TTM)99.05
% RANGE2.32%
EPS(TTM)2.361
P/E(FORWARD)24.18
P/B-126.4313
BVPS-1.8497
DIVIDEND6.92
P/S6.76
BETA--
DIV YIELD2.96%
FREE FLOAT MKT CAP411.19B
SHARES OUTSTANDING1.77B
NEXT EARNINGS04/23-04/27
FREE FLOAT1.76B
LOT SIZE1
EX-DATE04/15/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·15h ago
February Dividends With 4 Raises: 1.6% Up To 14.5%
PR Newswire·15h ago
AbbVie to Present at the Leerink Partners Global Healthcare Conference
TipRanks·15h ago
Analysts’ Top Healthcare Picks: Zymeworks (ZYME), AbbVie (ABBV)
TipRanks·17h ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Simply Wall St·19h ago
AbbVie Expands Rare Oncology And Immunology With New U.S. Manufacturing Investment
Benzinga·1d ago
AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson
The Motley Fool·1d ago
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors
Seeking Alpha·1d ago
AbbVie sees positive late-stage results for subcutaneous Skyrizi in Crohn's
Same Industry
Name/Symbol
Change%
Price